Vaping and Tobacco Use: Background, Epidemiology, Regulatory Issues, Safety (2025-2026 Recording)-Vaping and Tobacco Use: Background, Epidemiology, Regulatory Issues, Safety Recording

Video Transcription

Video Summary

Dr. Maureen Strom presented an overview of tobacco and vaping, focusing on epidemiology, safety, regulation, and treatment. She traced tobacco’s long history, from indigenous use and commercialization after Columbus to the rise of cigarettes through mechanized production and subsequent public health regulation. Smoking rates have declined over time due to evidence of harm, taxes, advertising restrictions, smoke-free laws, and cessation efforts, but tobacco still causes about 490,000 deaths annually in the U.S. and major healthcare costs.<br /><br />She emphasized disparities: smoking and nicotine use remain higher among people with less education, uninsured and LGBTQ communities, rural and Indigenous populations, and some racial/ethnic groups. Youth initiation is a major concern, with most smokers starting before age 25. Flavored products, menthol, and youth-targeted marketing have contributed to initiation and addiction.<br /><br />The talk described combustible and non-combustible tobacco products, and the evolution of e-cigarettes and vapes. Vapes are not harmless “vapor” devices but aerosol generators that can expose users to nicotine, toxins, and thermal degradation products. She discussed Juul, nicotine salts, product proliferation, and regulatory loopholes. Youth vaping has declined from peak levels, but e-cigarettes remain the most used tobacco product among students, and vaping marijuana is increasingly common.<br /><br />Dr. Strom reviewed nicotine neurobiology, dependence, withdrawal, screening tools like the Fagerström test and HSI, and treatment options including counseling, quit lines, nicotine replacement therapy, bupropion, and varenicline. She also covered regulatory history and current challenges in controlling flavored and disposable products.

Keywords

tobacco

vaping

epidemiology

nicotine dependence

public health regulation

smoking cessation

e-cigarettes

youth initiation

flavored tobacco

menthol

nicotine replacement therapy

bupropion

varenicline

health disparities